European Union - English - EMA (European Medicines Agency)

almirall, s.a. - eflornithine - hirsutism - other dermatological preparations - treatment of facial hirsutism in women.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - eflornithine monohydrate chloride - cream - 115mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - dimethyl fumarate - gastro-resistant tablet - 120mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - dimethyl fumarate - gastro-resistant tablet - 30mg

European Union - English - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - keratosis, actinic - antibiotics and chemotherapeutics for dermatological use - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almirall ltd - diclofenac sodium - cutaneous gel - 30mg/1gram

European Union - English - EMA (European Medicines Agency)

almirall s.a - tildrakizumab - psoriasis - immunosuppressants, interleukin inhibitors, - ilumetri is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.

European Union - English - EMA (European Medicines Agency)

almirall, s.a. - lebrikizumab - dermatitis, atopic - other dermatological preparations - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.

European Union - English - EMA (European Medicines Agency)

almirall s.a - dimethyl fumarate - psoriasis - immunosuppressants - skilarence is indicated for the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.